Pidotimod

Drug class: Immunostimulant

• Outstanding Immuno stimulant and immune-modulatory agent, it is clinically proven to enhance both innate and adaptive immunity.
• It increases the level of immunoglobulin and activates CTL responses to fight against infectious diseases. (Cytotoxic T lymphocyte: controls viral infection)
• Attenuates chronic inflammation which contributes to lung damage and stops recurring respiratory infections.
• Exceptional anti-inflammatory agent reduces levels of inflammatory markers like CRP in the body.
• Effectively improves clinical symptoms of respiratory tract infections such as cough, dyspnea, asthma, anorexia, sputum, and acute exacerbations.
• Possess an excellent safety profile without an increase in the frequency of side effects or autoimmune disorders.
• Reduces the need for hospitalization, recurrence and duration of recurring respiratory tract infections in pediatric patients.
• Absorbs faster, palatable and its liquid form is easy to swallow and gives better patient compliance.
• Also aid in the treatment and prevention of skin allergies like chronic idiopathic urticarial.